GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (FRA:ZOE) » Definitions » Short-Term Debt

Zoetis (FRA:ZOE) Short-Term Debt : €22 Mil (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Zoetis Short-Term Debt?

Zoetis's Short-Term Debt for the quarter that ended in Mar. 2024 was €22 Mil.

Zoetis's quarterly Short-Term Debt increased from Sep. 2023 (€2 Mil) to Dec. 2023 (€3 Mil) and increased from Dec. 2023 (€3 Mil) to Mar. 2024 (€22 Mil).

Zoetis's annual Short-Term Debt increased from Dec. 2021 (€0 Mil) to Dec. 2022 (€1,276 Mil) but then declined from Dec. 2022 (€1,276 Mil) to Dec. 2023 (€3 Mil).


Zoetis Short-Term Debt Historical Data

The historical data trend for Zoetis's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Short-Term Debt Chart

Zoetis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 450.00 496.49 - 1,276.29 2.75

Zoetis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.80 1.85 1.87 2.75 22.08

Zoetis Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Zoetis Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Zoetis's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Zoetis (FRA:ZOE) Business Description

Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis (FRA:ZOE) Headlines

No Headlines